Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Gadopentetate Dimeglumine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioAdaptives Announces Initial Investigation Results on Pluripain
    BioAdaptives Announces Initial Investigation Results on Pluripain

    24 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/24/2391246/0/en/BioAdaptives-Announces-Initial-Investigation-Results-Pluripain-Improves-Symptoms-of-Gadolinium-Deposition-Disease.html

    GLOBENEWSWIRE
    24 Feb 2022
    Share Share
    Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA
    Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA

    27 Dec 2017

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gadolinium-based-contrast-agents-update-from-guerbet-llc-on-us-food-and-drug-administration-fda-requirements-300575505.html

    PR NEWSWIRE
    27 Dec 2017
    Share Share
    EMA’s PRAC Seeks to Suspend Four Imaging Agents
    EMA’s PRAC Seeks to Suspend Four Imaging Agents

    17 Mar 2017

    // Zachary Brennan RAPS

    http://www.raps.org/Regulatory-Focus/News/2017/03/16/27131/European-Regulatory-Roundup-EMA%E2%80%99s-PRAC-Seeks-to-Suspend-Four-Imaging-Agents-16-March-2017/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails

    Zachary Brennan RAPS
    17 Mar 2017
    Share Share
    Celgene Announces Positive Phase 3 Study Results for MS Drug Ozanimod
    Celgene Announces Positive Phase 3 Study Results for MS Drug Ozanimod

    17 Feb 2017

    // Celgene Corporation DDDMAG

    http://www.dddmag.com/news/2017/02/celgene-announces-positive-phase-3-study-results-ms-drug-ozanimod

    Celgene Corporation DDDMAG
    17 Feb 2017
    Share Share